Figure 1From: Elevated urinary levels of urokinase-type plasminogen activator receptor (uPAR) in pancreatic ductal adenocarcinoma identify a clinically high-risk group Correlation between plasma suPAR concentration and urinary suPAR/creatinine level in pancreatic adenocarcinoma patients.Back to article page